ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...

As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...

Millions of myelin-producing cells have been mapped in the mouse brain, advancing our understanding of nervous system disorders.

Ultragenyx Pharmaceutical Inc. ( RARE) TD Cowen 46th Annual Health Care Conference March 2, 2026 1:50 PM EST ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

Payward, a unified financial infrastructure platform powering Kraken, today announced that Kraken Financial, its Wyoming-chartered bank, has been granted a Federal Reserve master account. The approval ...

Johns Hopkins scientists say they have used 3D imaging, special microscopes and artificial intelligence (AI) programs to construct new maps of mouse brains showing a precise location of more than 10 ...

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...

Every once in a while, a single instrument arrives and rewrites the rules. Not just for music, but for culture itself. Think about it. A strip of brass and a few keys gave birth to jazz. A solid block ...

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, ...